Browse Category

Biotechnology News 15 October 2025 - 17 October 2025

Praxis (PRAX) Stock Skyrockets 180% on Game-Changing Tremor Drug Trial; Analysts See ‘Blockbuster’ Upside

PRAX Stock Soars on Historic Trial Win Praxis Precision Medicines stock has seen a record-breaking spike in recent days after announcing landmark clinical trial results. On October 16, PRAX shares closed at $162.71, up about 183% in a single session

17 October 2025

GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News

Strategic Samsung Partnership GRAIL’s shares surged after it announced a deal on Oct. 16 to partner with Samsung in Asia. The binding Letter of Intent involves Samsung C&T and Samsung Electronics investing $110 million in GRAIL at $70.05 per share, with

16 October 2025

Biotechnology · Cancer Research · Health News · NASDAQ:GRAL · Partnerships · Stock Market

Moderna’s Wild Ride: Vaccine Hopes Fuel Stock Pop Amid “One-Hit Wonder” Fears

Stock Rebounds on Moderna’s “Make-or-Break” Week Moderna’s stock is back in the spotlight after a turbulent week of news that sent the Nasdaq-listed shares swinging. On Wednesday, MRNA jumped over 5%, climbing to around $27.7 by market close marketbeat.com. The

16 October 2025

Biotechnology · COVID-19 · NASDAQ:MRNA · Pharma News · Stock Market · Vaccines

Praxis Precision (PRAX) Stock Skyrockets on Game-Changing Phase 3 Results – What Experts Say

Market Outlook With the stock now trading well above $150, investors are debating how much further PRAX could rise. If ulixacaltamide wins approval, analysts believe it could capture a sizable ET market. However, success in neurology trials can be binary

16 October 2025

Biotechnology · Financial Analysis · Investing · NASDAQ:PRAX · Pharma News · Stock Market

Sana Biotechnology (SANA) Stock Skyrockets on ‘100-Bagger’ Hype – Experts Debate What’s Next

Surge Fueled by a ‘100-Bagger’ Tweet Sana Biotechnology’s stock skyrocketed mid-week after a bold endorsement from a well-known tech investor. On Oct. 15, SANA shares jumped over 25% in a single session, closing at $5.62 (up from $4.45 the day

16 October 2025

Biotechnology · Financial News · Investment Strategies · Market Analysis · NASDAQ:SANA · Stock Market

Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Biotech Bombshell: Omeros Stock Skyrockets on $2.1B Novo Nordisk Deal – What’s Next?

Stock Performance: Recent Surge and Volatility Omeros shares were trading around $4–$4.60 through early October, then exploded on Oct. 15. Data from the company’s IR site show OMER jumped from $4.10 (Oct 14 close) to $10.42 by Oct 15 close

16 October 2025

Biotechnology · Investment Trends · Mergers & Acquisitions · NASDAQ:OMER · NYSE:NVO · Pharma News · Stock Market

Sana Biotech Shares Skyrocket on 100x Hype – What’s Behind the Rally?

Stock Surge Fueled by ‘100-Bagger’ Tweet On Oct. 15, SANA spiked as investors reacted to hedge fund manager Eric Jackson’s bullish call. In a post on X (formerly Twitter), Jackson proclaimed: “Biotech is back. Rates are falling, inflation is cooling,

15 October 2025

Biotechnology · Financial Trends · Investment News · Market Analysis · NASDAQ:SANA · Stock Market

Recursion RXRX Stock Skyrockets: AI Breakthroughs and Big Pharma Deals Ignite Biotech Surge

Volatile Stock Performance in October 2025 Recursion’s stock showed wild swings in early October. On Oct 7, 2025 the shares fell about 5.4% to ~$5.23 amid a broad market slump nasdaq.com. The very next day (Oct 8) the stock rebounded

15 October 2025

Artificial Intelligence · Biotechnology · Investment Trends · NASDAQ:RXRX · Pharma Industry · Stock Market

Origin Agritech’s SEED Stock Skyrockets 92% on China Seed Breakthroughs & Trade Buzz

SEED Stock Soars on Market Momentum Origin Agritech’s stock skyrocketed this week, delivering eye-popping gains for investors. On Tuesday night, SEED shares surged over 92% in after-hours trading following a flurry of positive developments benzinga.com. The price spiked from the

15 October 2025

Agriculture · Biotechnology · China Market · NASDAQ:SEED · Stocks · Trade News

Evaxion (NASDAQ:EVAX) Stock Rockets After AI-Powered Cancer Vaccine Breakthrough

Evaxion’s stock jump in mid-October comes as the company lines up important clinical updates and validates its AI-driven vaccine technology. On Oct 13, Evaxion announced it will present two-year data from its Phase 2 trial of EVX-01 (a personalized cancer vaccine

15 October 2025

Artificial Intelligence · Biotechnology · Cancer Research · Medical Innovation · NASDAQ:EVAX · Stock Market

Arcadia Biosciences Stock Rockets Amid Trade News – What’s Behind RKDA’s Wild Ride?

In-Depth: Arcadia’s stock price (RKDA) has been extremely volatile in October 2025, jumping ~68% pre-market on Oct 15. The rally was sparked by a Trump tweet on China trade and follows mixed Q2 results. In the past few days RKDA’s

15 October 2025

Biotechnology · Company News · Financial Analysis · Investing · NASDAQ:RKDA · Stock Market

Genprex (NASDAQ:GNPX) Stock Skyrockets 40% on Lung Cancer Gene Therapy Breakthrough

Stock Price & Recent Performance Genprex shares have been extremely volatile. After surging over 30% during regular hours on Oct 14, 2025, to about $0.25, the stock jumped another 41% in after-hours trading (October 14) to roughly $0.36 on the

15 October 2025

Biotechnology · Gene Therapy · Health News · Lung Cancer · NASDAQ:GNPX · Stock Market

Previous 1 … 5 6 7 8 9 10 Next

Go toTop